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ABSTRACT 
Antral mucosal biopsies were examined microbiologically and 
histologically for the presence of Campylobacter pylori in 224 
patients with upper gastrointestinal symptoms. One hundred and 
eighty three (83%) patients were found to harbour Campylobacter 
pylori in their gastric mucosa. Campylobacter pylori was 
strongly associated with the presence of histological gastritis 
(93%) and was detected in only 10% of 30 patients whose gastric 
biopsies showed normal histology. Endoscopically diagnosed 
duodenal lesions were more strongly associated with the presence 
of Campylobacter pylori than were gastric lesions (p <0.001). 
A variety of laboratory methods were evaluated to determine 
the sensitivity and specificity to detect the presence of 
Campylobacter pylori. Histology was the most sensitive and 
specific method to detect the presence of Campylobacter pylori. 
Although culture was highly specific, it was less sensitive than 
histology in detecting Campylobacter pylori in gastric 
antral mucosal specimens . The "conventional" gastric urease 
assay, although specific, needs be performed under 
controlled conditions (37°C) for optimal results. The "one-
minute" urease assay was more sensitive than the 
"conventional" gastric urease assays and was highly 
specific. ELISA to detect specific-IgG antibodies to 
Campylobacter pylori was a moderately sensitive non-invasive 





Although the presence of spiral bacteria on gastric mucosa 
of post-mortem specimens was noted by histopathologists in the 
early part of this century (1), their possible role as pathogens 
was never clarified. It was only after Warren and Marshall (2) 
reported the isolation of a Campylobacter-like microorganism, now 
named Campylobacter pylori (C. pylori) (3), from the gastric 
mucosa of humans in 1983, that worldwide interest and research 
into their possible role in peptic ulcer disease and gastritis 
was initiated. 
The strong association between these bacteria and 
histological gastritis and duodenal ulceration has since been 
confirmed by many investigators worldwide (2,4 - 10). Little, 
however, is known about its occurrence in South African patients. 
There is now strong evidence that C. pylori causes gastritis 
(11,12) and that treatment with antimicrobial agents such as 
bismuth salts in combination with ampicillin, metronidazole, 
tetracycline, erythromycin or furazolidine may be followed by 
eradication of this organism, normalisation of gastric histology 
and may result in lower relapse rates of peptic ulceration when 
compared to the use of H2-antagonists alone (13 - 17). 
Diagnosis of C. pylori infection has largely been based on 
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isolation of these bacteria from gastric biopsy specimens 
obtained at endoscopy or by direct visualisation on stained 
tissue sections. The results of both culture and histology may 
only be available after several days and thus efforts have been 
made to establish more rapid techniques and to develop non-
endoscopic methods to detect the presence of ~. pylori, so as not 
to delay the early initiation of specific therapy. 
A prominent feature of ~. pylori is the production of large 
quantities of extracellular urease (5,18). This enzyme has been 
postulated to play an important role in the pathogenesis of 
gastritis and peptic ulceration (19,20). Investigators have also 
used this property of ~. pylori as an indirect, rapid marker of 
the presence of ~. pylori in biopsy specimens (21 - 24). 
Since persons infected with C. pylori develop both local and 
serum antibodies to this organism (25 - 28), much interest has 
been devoted to serological tests to detect antibody to ~ .pylori 
as a potential non-endoscopic approach to diagnose C. pylori 
infection. 
Despite growing interest in ~. pylori-associated 
gastrointestinal disease, optimal methods to detect its presence 
have not been established. 
This paper reports the findings of three separate studies: 
I 
the first, a prospective study, was designed to determine the 
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prevalence of £. pylori in a series of patients with upper 
gastrointestinal symptoms, referred for endoscopy, at King Edward 
VIII Hospital in Durban; the second and third parts of the study 
were designed to investigate the sensitivity and specificity of 
various techniques to detect the presence of C. pylori. 
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PATIENTS AND METHODS 
Two hundred and twenty four newly presenting African and 
Indian patients with upper gastrointestinal symptom~ for which 
endoscopy of the upper gastrointestinal tract was indicated, were 
included in the first part of the study. Informed consent was 
obtained from all patients and the study was approved by the 
Ethics Committee of the Faculty of Medicine, University of 
Natal. During endoscopy, two antral mucosal biopsies were taken 
from within 5 centimeters of the pylorus. One was placed into 
brucella broth for bacteriological culture and the other into 10% 
formalin prior to histological examination. The endoscopic 
diagnoses were recorded and known only to the endoscopist until 
the end of the study. 
Histology : Formalin fixed biopsies were routinely processed and 
sections were stained with both haematoxylin and eosin (H& E) 
and by the Warthin-Starry technique and examined for both the 
presence of gastritis and IIcampylobacter-like organisms ll • On 
histological examination, any gastritis detected was classified 
into chronic superficial and chronic atrophic gastritis. The 
pattern of inflammation was further categorised as lIactive ll or 
lIinactive ll • "Active ll gastritis req uired the presence of 
polymorphs, plus lymphocytes and plasma cells infiltrating the 
lamina propria together with degenerative changes; when 
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polymorphs were absent, the gastritis was classified as 
lIinactive ll • C. pylori were usually recognised as curved or 
spiral organisms, usually lying in the mucous layer and adjacent 
to the epithelium, especially in the gastric glands and at the 
junctions between the cells (plates 1 and 2). 
Microbiology: Antral biopsies in brucella broth were finely 
minced with sterile blades and inoculated onto chocolate agar 
within 3 hours of collection. The plates were then incubated 
microaerophilically, using IIGaspak ll envelopes without catalyst 
(BBl Microbiology Systems, Cockeysville, MD), for up to 10 days 
and were examined on days 3, 7 and 10 for growth. Tiny clear 
colonies (plate 3) were identified as C. pylori by Gram stain, 
positive oxidase test, positive catalase test and characteristic 
rapid urease reaction (5). A specimen was considered to be 
negative for f.: pylori if no growth occurred within 10 days 
incubation. The initial 40 specime ns were also cultured on a 
selective medium, Skirrows formulation of campylobacter agar 
(29). Initial isolates were also tested for sensitivity to 
nalidixic acid and cephalothin. 
Endoscopes and biopsy forceps were disinfected with 2% 
gluteraldehyde solution and rinsed with sterile water between 
examinations. Bacteriological testing of the instruments after 
decontamination yielded no growth of C. pylori, indicating that 
this bacterium was not being transferred between patients. 
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In the second study, microbiological culture, histology and 
gastric urease assays, which required the taking of gastric 
antral biopsy specimens at the time of upper gastrointestinal 
endoscopy, and an enzyme-linked immunosorbent assay for the 
detection of specific-IgG antibodies to C. pylori in serum 
specimens were evaluated. One hundred newly presenting patients, 
in whom upper gastrointestinal endoscopy was conducted for 
symptoms referrable to the upper gastrointestinal tract, were 
included in the study. At endoscopy, three antral mucosal 
biopsies were taken from each patient within 5 centimeters of the 
pylorus. These were processed for histology, microbiological 
culture and gastric urease assays. A sample of venous blood was 
collected from each patient for measurement of antibodies to 
C. pylori. 
Specimens for histological examination were processed as in 
the first part of the study. However, sections were stained only 
with H & E. The Warthin-Starry technique was discontinued in 
this part of the study. 
Microbiological culture and gastric urease assay at 37°C: 
A second antral biopsy was transported in brucella broth to 
the microbiology laboratory and usually processed within 3 hours 
of collection. The specimen was first inoculated onto chocolate 
agar and then placed into 2 ml of 2% Christensen's urea broth (30). 
Inoculated chocolate agar plates were incubated as in the first 
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part of the study and suspect colonies identified by positive 
oxidase, positive catalase and rapid urease reactions (5). 
. 0 Inoculated Christensen's urea broth was Incubated at 37 C 
overnight to detect preformed urease activity. The principle of 
the gastric urease assay is that preformed urease in the biopsy 
specimen, colonised or infected with C. pylori, converts urea to 
ammonia. This, in turn, leads to a pH change in the test medium 
and to a colour change of the phenol red indicator. A colour 
change from yellow to pink or orange indicated a positive test. 
The specimen was considered to be urease negative if no colour 
change developed after 18 hours incubation. 
Gastric urease assay at room temperature: 
A third gastric antral biopsy specimen was placed 
immediately, in the endoscopy room, into 2 ml of 2% Christensen's 
urea broth and kept at room temperature for up to 18 hours before 
being examined for any colour change, as described above. 
Serology: 
Antigen preparation: Stored strains of ~. pylori were grown on 
chocolate agar for 5 days in a microaerophilic environment, 
harvested in normal saline, centrifuged at 1500 x g for 10 
minutes, washed twice in phosphate buffered saline (PBS pH 7.2) 
and then fixed in 4% formaldehyde, washed again and stored at 4°C 
in PBS with 0.1% sodium azide for a maximum of 2 days until used 
as antigen. 
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ELISA: The indirect enzyme-linked immunosorbent assay (ELISA) 
was used to measure anti-~. pylori IgG antibodies (31). Each 
well of polystyrene flatbottom microtitre plates (Dynatech M129, 
T & C Scientific Supplies, Durban) were coated with 100 ~l of 
18.7S x 10 6 formalized intact cells of ~. pylori in coating 
buffer (O.OSM carbonate pH 9.6) and incubated for 2 hours at room 
temperature in a humid container. Plates were washed with O.OSM 
tris-0.1M NaCl buffer (TS)(pH 8.0) containing O.OS % (w/v) Tween 
20 (TST) in an ELISA shower (32). Excess TST was "flicked off" 
and the plate was padded dry on absorbent material. 
Fifty microlitres of patient's serum, diluted 1/100 in TS, was 
then added to duplicate we 11 s and incubated for 1 hour at 4SoC in 
a humid container. The plates were washed with 500 ml of TST, 
dried and incubated with 50 fl of a 1/1000 di lution of gamma-
chain specific goat anti-human IgG conjugated to horse radish 
o 
peroxidase (Sigma Chemicals, St Louis, USA) for 1 hour at 4S C in 
a humid container. The plates were washed as previously 
described and 50 ~l of chromogenic substrate (hydrogen 
peroxide/ortho-phenylene diamine) (33) was added to each well and 
plates were incubated for S minutes in the dark at room temperature. 
The reaction was stopped by adding SO ~l of 1.SN hydrochloric 
acid (HCI) (33) to each well. The optical density (OD 492 nm) 
was measured using a Titertek Multiscan MicroELISA plate reader 
(Flow Laboratories). Absorbance values of 0.300 or more were 
regarded as positive, whereas values of less than 0.300 were 
1 1 
regarded as negative. 
In the third part of the study , histology, microbiological 
o 
culture, the gastriC urease assay performed at 37 C, and a "one-
minute" gastriC urease assay (24) were evaluated in 100 
consecutive patients with upper gastro-intestinal symptoms 
referred for upper gastrointestinal endoscopy. Gastric antral 
mucosal biopsy specimens for histology, microbiological culture 
o 
and gastriC urease assay at 37 C were performed as in the first 
and second part of the study. In addition, a third gastric 
antral biopsy specimen was placed i mmediately, in the endoscopy 
room, into a Bijoux bottle containing 1 ml of 10% w/v urea in 
deionised water at pH 6.8, and 2 drops of 1 % phenol red. A 
positive result was recorded if the colour changed from yellow to 
pink within one minute. 
( 
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~. pylori isolates, throughout the study period, fulfilled 
the criteria reported by others (3,6,7), being Gram-negative, 
curved or U-shaped, oxidase positive, catalase positive and a 
strongly urease positive. All initial isolates were resistant to 
nalidixic acid and sensitive to cephalothin on disc diffusion 
testing. 
First part of study 
Of the 224 patients studied in the first part of the study, 
c. pylori was cultured in 146 (65%) and seen on histology in 179 
(80%) of the patients. In 183 (82%) the microorganism was either 
cultured and/or seen on histology. In only 4 patients was the 
microorganism cultured but not seen on histology. 
The association of C. pylori with endoscopic findings is 
shown in table I. C. pylori was cultured and / or seen on 
histology in 65 (97%) of 67 patients with duodenal ulceration, 19 
(95%) of 20 patients with duodenal erosions, 9 (90%) of 10 
patients with duodenal erythema, 13 (62%) of 21 patients with 
gastric ulceration, 1 (33%) of 3 patients with gastric erosions 
and in 8 (62%) of 13 patients with gastric erythema. C. pylori 
was detected in 53 (76%) of 70 patients in whom endoscopy was 
reported as normal and fifty (71%) of these 70 patients had 
histological evidence of gastritis. 
The association between the presence of ~. pylori, as 
detected by culture and / or histology, and histologically 
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diagnosed gastritis is shown in table 11. c. pylori was detected 
"--
in 167 (94%) of 177 patients with chronic superficial, active 
gastritis, in 10 (83%) of 12 patients with chronic superficial 
gastritis without activity and in 3 (60%) of 5 patients with 
chronic superficial gastritis with intestinal metaplasia. Thus, 
c. pylori was detected in 180 (93%) of 194 patients with 
histological evidence of gastritis. In contrast, the 
, 
microorganism was cultured and / or seen on histology in only 3 
(10%) of 30 patients with normal antral histological features. 
In 1 of the 3 patients, the microorganism was both cultured and 
seen on hi~tology; in the other 2 patients it was cultured but 
not seen on histology. The latter may reflect a sampling error 
due to the patchy distribution of gastritis or result from low 
numbers of organisms in the biopsy specimen sent for histology. 
One hundred and thirty of 152 male patients (86%) were ~. 
pylori-positive in contrast to 53 (74%) of 72 females studied. 
This difference was significant (p<0.05) (table Ill). There was 
no statistically Significant difference in the prevalence of 
c. pylori in Indian and African patients (p = 0.38) (table IV). 
Second part of study 
c. pylori was cultured in 57 and seen on histology in 82 of 
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the 100 patients studied in the second part of the study. In 84 
patients ~. pylori was either cultured and / or seen on 
histology. ~. pylori was cultured but not seen on histology in 
only 2 patients. 
Detection of ~. pylori by culture and / or histology, or 
both, was taken as the "gold standard" with which gastric urease 
assays and serology, to detect specific-IgG antibody to 
C. pylori, were compared. 
Table V shows that histology was the most sensitive and 
specific technique evaluated to detect C. pylori infection. 
Although culture was 100% specific, it was much less sensitive 
than histology (68% vs 98%). The gastriC urease assay performed 
under controlled conditions (37°C) was more sensitive (71% vs 
55%)~ but less specific (81% vs 100%) than when performed at room 
temperature. Although detection of specific-IgG antibodies to 
~. pylori in sera was relatively sensitive (82%), this test had 
low specificity (38%). Specific-IgG antibodies to ~. pylori were 
detected in 10 (62.5%) patients in whom the organism was neither 
detected by culture nor histology. 
The correlation between htstologically diagnosed gastr1tis 
and the detection of ~. pylori by the various methods evaluated 
is shown in table VI. Chronic, superficial active gastritis was 
detected in 90 patients. In 10 patients, no abnormality was 
detected on histological examination. Chronic, superficial 
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inactive gastritis and chronic atrophic gastritis were not 
detected in any of the patients studied. ~. pylori was detected 
in 80 (89%) of patients with histological evidence of gastritis 
by histology and / or culture. In contrast, this microorganism 
was cultured or seen on histology in only 2 (20%) of patients 
with normal histology. The gastric urease assays detected C. pylori 
in 64% and 51% of patients with histological gastritis when 
o performed at 37 C and room temperature respectively. Specific-
IgG antibodies to ~. pylori were detected in 76% of patient with 
histological gastritis; serology also appeared relatively 
specific (90%) in the detection of C. pylori-associated 
gastritis. A positive antibody result was uncommon (10%) in the 
absence of histological gastritis. 
Third part of study 
One hundred newly presenting patients were included in the 
third part of the study (table VII). ~. pylori was detected in 
88 by culture and / or histology. Histology again was the most 
sensitive technique evaluated to detect the presence of C. 
pylori. Culture detected 79% of L. pylori-positive patients. 
The lIone-minutell gastric urease assay detected 86% of .£.: pylori-
positive patients and was 100% specific in contrast to the 
gastric urease assay performed at 37°C, which detected 70% of 
~. pylori-positive patients. 
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DISCUSSION 
~. pylori is a redescribed microorganism which has been 
implicated in gastroduodenal disease. It is a microaerophilic 
spiral Gram-negative bacterium whic h is unique in producing large 
amounts of extracellular catalase and abundant amounts of urease 
(2,6,10,34). Both these factors may be important in allowing the 
microorganism to reside in intimate contact with the gastric 
mucosal cells beneath the mucous layer. 
These bacteria were initially referred to as "gastric 
campylobacter-like organisms" (GClO); later the scientific "name 
Campylobacter pyloridis was proposed, since Marshall and other 
investigators had initially cultured it from the pyloric area of 
the stomach (10). This was changed to C. pylori in 1987 (3). 
Since the ultrastructure, flagellae and cellular fatty acid 
profile of ~. pylori is significantly different from that of the 
intestinal campylobacters, further taxonomic changes are likely 
(18,35,36). 
In this study, ~ pylori was detected in 93% of patients 
with histological evidence of gastr i tis compared to 10% of 
patients with normal histology (tab l e II). This is in keeping 
with the findings of others (2,4 - 8) suggesting that ~. pylori 
is strongly associated with histological gastritis and is only 
rarely found in gastric biopsy specimens which show no evidence 
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of inflammation. The chronic gastritis with which ~. pylori is 
associated, usually involves the antrum and is commonly called 
non-autoimmune (type B) gastritis (37) in order to distinguish it 
from the gastritis found in pernicious anaemia (type A 
gastritis). However, there is considerable disagreement as to 
whether the activity of the gastritis is consistently associated 
with the presence of this organism. Marshall and Warren1s claim 
(38) for a special relationship with the activity of the gastritis, 
as signified by the degree of polymorphonuclear leucocyte 
infiltration, is not supported by all investigators (6,7,39). In 
this study, ~. pylori was detected in 94% of patients with 
chronic superficial gastritis with activity, compared to 83% of 
patients with chronic superficial gastritis without activity 
(p = 0.5), suggesting that activity is not an important 
determinant for its presence. 
C. pylori was detected in 97% of patients with duodenal 
ulceration, 95% of patients with duodenal erosions, 90% of 
patients with duodenal erythema, 62% of patients with gastric 
ulceration, 33% of patients with gastric erosions and 62% of 
patients with gastric erythema (table I). This suggests that 
there is a higher correlation between ~. pylori and endoscopic 
observation of duodenal lesions, than between C. pylori and 
- , 
endoscopic findings of gastric lesions (p <0.001). This is in 
agreement with the findings of several other investigators who 
have failed to show as strong a correlation with gastric ulcers 
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as there is with duodenal ulcers (5,7,8,10,38). Price et al (7) 
also found a higher correlation between the presence of 
C. pylori, in antral biopsies, with duodenal ulceration than with 
gastric ulceration (81% vs 57%) while Marshall et al (10) found 
C. pylori to be associated with 90% of duodenal ulcers and 70% of 
gastric ulcers. However, unlike other reports (7}, ~. pylori was 
less commonly found in patients wi t h gastric ulcerations and 
gastric erythema than in patients with normal endoscopic findings 
(62% vs 76%). 
The prevalence of ~. pylori in males is significantly more 
common than in females (P<0.05) (table Ill). This confirms the 
findings of Rokkas et al (40). Rouvraj (41) and Rotter 
(University of Vienna; personal communication), however, did not 
show this sexual difference. There was no statistically 
significant difference between the presence of C. pylori in 
Africans and Indians (p = 0.38) (table IV). 
The Significance of these findings is uncertain. The 
statistically significant correlation between ~. pylori and 
histological gastritis, duodenal ulceration, duodenal erythema 
and duodenal erosions, however, does not prove a causal 
relationship. Evidence for a causal relationship (i.e. 
pathogenicity) is provided by several recent publications. 
Marshall fulfilled Koch's postulates when he developed gastritis 
within 7 days of ingesting a culture suspension of C. pylori 
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isolated from a patient (11). Subsequently Baskerville and 
Newell were able to infect rhesus monkeys with a human strain of 
c. pylori (42). Treatment studies have shown that agents with 
in-vitro activity against ~. pylori, such as bismuth salts, 
metronidazole and erythromycin are as successful as H-2 
antagonists in healing peptic ulce r s but with a significantly 
lower relapse rate (11,23,24). Drumm et al indicated that 
~. pylori is specifically associated with primary antral 
gastritis in children and does not appear to colonise gastric 
mucosa secondary to inflammation such as may follow ingestion of 
prednisone and non-steroidal anti-inflammatory agents or 
accompany Crohn's disease and eosinophilic gastritis (43). 
Finally, IgG and IgA antibodies to ~. pylori have been shown to 
be present in the serum of patients harbouring the microorganism 
(6) and patients with duodenal ulceration have been found to have 
significantly higher antibody levels than healthy adults and 
children (25). Although these reports are only circumstantial, 
they seem to support the view that C. pylori may indeed be a 
cause of gastritis and gastroduodenal disease. It is important, 
however, to develop an animal model to investigate the mechanisms 
underlying the ~. pylori-associate d gastroduodenal disease and 
study the treatment thereof, without the need for human 
volunteers. 
Many studies are in progress to assess the effects of anti-
ulcer therapy and antibiotics on ~. pylori-associated gastritis 
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in an effort to elucidate any causal relationship with peptic 
ulcer disease. Reliable methods for the detection of C. pylori 
are essential to such studies. 
The association between C. pylori and histological gastritis: 
The second part of the study confirms the observations of 
the first part of the study, namely that C. pylori is strongly 
associated with histological gastritis, especially chronic, 
superfici~l active gastritis (table VI). It was detected by 
histology, culture and serology in 89%, 61% and 76% of patients 
with chronic, superficial gastritis respectively. These bacteria 
are occasionally found in fundal gastriC mucosa mainly in 
association with chronic antral gastritis (44). In the duodenum, 
~. pylori is found only in the presence of active duodenal 
inflammation in areas of gastriC metaplaSia (45,46). Thus the 
association between C. pylori and type B gastritis seems unique, 
tending to support the view that this bacterium has a pathogenic 
role in this lesion. 
Histology: 
Histology was the most sensitive and specific technique 
studied to detect the presence of C. pylori infection. It was 
detected on histology in 98% and 97% of ~. pylori-positive 
patients in the second and third parts of the study respectively 
(tables V and VII). The characteristic curved morphology of 
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C. pylori and its close association with the mucosal surface 
allows presumptive diagnosis of ~. pylori in gastric biopsy 
specimens. These bacteria are faintly visible on H & E sections 
and appear to be more easily recognised in sections stained by 
the expensive and time consuming Warthin-Starry technique. We, 
however, did not use the Warthin-Starry stain (2) to detect the 
presence of C. pylori in gastriC biopsy specimens in the second 
and third parts of the study because this stain did not detect 
~. pylori in sections found to be negative on H & E staining in 
the first part of the study. Controversy seems to exist as to 
which histological stain is best for the detection of C. pylori 
in gastric biopsy specimens. McMullen et al (47) have suggested 
the use of the Gimenez stain in view of the poor results they 
obtained with the H & E and Warthin-Starry stains. Others have 
suggested the use of acridine orange and the Dieterle stain 
(9,48). The H & E stain, however, in the hands of an experienced 
histopathologist, appears to be adequate. Microscopic techniques, 
which have been employed by others, but were not evaluated in 
these studies, include phase contrast microscopy (49), the Gram 
stain and indirect immunofluoresce nce (50). 
Although histology is both very sensitive and specific, the 
patient cannot be treated immediately with "appropriate" drugs 
since it usually takes several days before a report is available. 
Culture: 
In all 3 studies culture was less sensitive than histology 
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for the detection of ~. pylori in gastric biopsy specimens which 
is in accordance with the findings of others (7,47). Culture was 
comparable in sensitivity, but more specific than the gastric 
o 
urease assay performed at 37 C and serology. 
Chocolate agar, the original medium used to recover the 
organism (2), was used successfully in our laboratory in most 
instances. Although yeasts, alpha-haemolytic streptococci and 
enterobacteriaceae were sometimes encountered , the isolation of 
~. pylori, on non-selective chocolate agar, did not pose a 
problem since it was the sole organism isolated in the majority 
of cases. The need for a selective agar such as the Skirrow 
formulation of campylobacter medium, which contains 7% lysed 
horse blood together with vancomycin, nalidixic acid and 
trimethoprim has been recommended by some (51,52). This 
selective medium, however, did not increase the yield of 
~. pylori isolates in the initial 40 specimens cultured in the 
first part of the study (data not shown) and was thus 
discontinued. Although contamination of biopsy specimens with 
oropharyngeal bacteria was not a major problem, care needs to be 
exercised in obtaining specimens. 
However, the detection of C. pylori by culture has obvious 
limitations: it is less sensitive than histology; it may take as 
long as 10 days for a result; and t he patient must make a return 
visit in order to obtain treatment on the basis of culture 
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results - this is also applicable to histology. The lower 
sensitivity of culture when compared to histology in this study 
may be explained by the fact that the success rate of culture 
declines significantly if the spec i men is not directly inoculated 
onto the growth medium (52). In addition, Goodwin et al (52) 
have shown that fine grinding of specimens increased the 
sensitivity of the culture results when compared to merely 
mincing the tissue. False negative findings may also have 
resulted from patient having taken bismuth preparations or 
antimicrobial agents prior to endoscopy, or may be due to patchy 
distribution of ~. pylori in the s t omach (52) . In addition, 
culture may not permit the detection of L. pylori when few 
organisms are present. Although culture in our hands was less 
sensitive than histology for the detection of L. pylori in 
gastric biopsy specimens, it is the only technique which allows 
the accurate identification of the bacterium and makes possible 
the determination of susceptibilty to antimicrobial agents, which 
is essential to the performance of therapeutic trials. 
Gastric urease assays: 
The urease activity of ~ pylori has attracted much interest 
including an approach towards a rapid diagnosis (21 - 24). This 
urease is a high molecular weight enzyme which exhibits a high 
affinity for urea and has significantly higher activity than the 
urease produced by enteric Gram negative bacilli such as Proteus 
spp. and Klebsiella spp. (53). 
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The sensitivity of the gastr i c urease assay performed at 
room temperature (55%) is lower than that obtained by McNulty and 
Wise (21). This lower sensitivity may be explained by the fact 
that gastric antral biopsy specimens were not crushed during 
inoculation, but were used "whole" as obtained. 
The optimum temperature of 43°C for ~. pylori urease 
activity (53) suggests that more rapid detection of the organism 
in gastric biopsies assayed in urea broth could be achieved if 
o tubes were incubated at 43 C. C. pylori urease is also more 
o active at 37 C than at room temperature, which may explain the 
o higher sensitivity of the urease assay obtained at 37 C (71%) in 
comparison to the assay performed at room temperature (55%) 
(table V). It would thus appear that conventional gastric urease 
o 0 assays should be performed at temperatures of 37 C or 43 C for 
optimum results. 
Although the gastric urease assay performed at 37°C was not 
significantly more sensitive than culture (p = 0.76), this test 
may have been more sensitive if large numbers of organisms 
probably were not removed from the surface of the specimen during 
initial inoculation of solid (chocolate) medium prior to 
inoculation of urea broth, and if there had been less delay in 
transport to the laboratory. 
Since the vast majority of positive gastric urease assays 
took longer than 6 hours to react positively (data not shown), 
25 
the conventional gastric urease assays (21 - 24) cannot be 
recommended as a reliable and rapid test to detect the presence 
of ~. pylori in gastric biopsy spe c imens. The "one-minute" 
urease assay was not significantly more sensitive than culture 
(p = 0.32) (table VII). This assay may be a potentially useful 
test to detect C. pylori since, if the test if positive, 
appropriate therapy may be initiated immediately. There were no 
false positive results with the "one-minute" urease assay, which 
appears to be a further advantage, since other urease-producing 
bacteria require prolonged culture and may be unable to effect a 
colour change in this test. A gas t ric urease assay is now 
commercially available as the CLO test (Delta West, Western 
A~stralia). This test, however, is expensive and requires 24 
hours incubation for optimal results (24). 
Serology: 
A serodiagnostic assay has been proposed as a primary 
screening proced~re to dete~t antibodies to ~. pylori and thereby 
eliminating the need for endoscopy to collect gastric biopsy 
specimens. Methods of measuring antibodies to C. pylori have 
included complement fixation tests (5), enzyme-linked 
immunosorbentassays (6,25 - 28,54,55) and immunoblotting 
(25,55,56). 
Athough ELISA is a well established method, the use of 
different antigens, such as whole bacteria, sonicated or acid-
26 
extracted antigens have resulted in varying sensitivies and 
specificities. 
We used whole, formalin-killed organisms (26) to detect 
specific-IgG to £. pylori. Specific-IgM was not sought 
because other authors have not found antibodies of this class to 
be useful in the serodiagnosis of C. pylori infection (26,54). 
Specific-IgG antibodies to C .pylori were detected in 76% of 
patients with £. pylori-associated gastritis and results showed a 
specificity of 90% (table VI) with a positive predictive value of 
98% and a negative predictive value of 29%. Thus a positive 
ELISA reaction provides strong presumptive evidence of 
histological gastritis. This observation is consistent with the 
findings of others (26,54,57). A negative ELISA, however, should 
be treated with circumspection, due to the low negative 
predictive value. As endoscopic findings alone appear to be 
poor indicators of C. pylori-associated gastritis, availability 
of a more specific ELISA may provide a useful screening test for 
the detection of C. pylori-associa t ed gastritis. 
In this study, 22 (24%) patients were seronegative but had 
C. pylori-associated gastritis (table VI). These false negative 
results are possibly due to lack of sensitivity of the ELISA used 
in the study. 
The ELISA described was able to detect specific-IgG 
27 
ant i b 0 die s t o~. P Y I 0 r i i n 82% 0 f pat i e n t sin who m ~. p y 1 0 r i 
was detected in gastric biopsy specimens by culture and / or 
histology (table V). In contrast to Dwyer et al (28), who did 
not detect antibodies to ~. pylori in any culture-negative 
patients, specific-IgG antibody to C. pylori was also detected 
in 10 of 16 (62%) patients in whom C· pylori was not detected by 
culture or histology. The significance of this finding remains 
unclear. A poss i ble explanation is that specific-IgG antibodies 
to C. pylori may persist after elimination or clearance of the - ~ 
organism and resolution of the gas t ritis. Jones et al (27) have 
shown that antibody to C. pylori may persist in some individuals 
for many years. 
Serological cross-reactions between ~. pylori and other 
Campylobacter species have been described (55), but do not appear 
to be relevant in the serodiagnosis of ~. pylori infection with 
the serum dilutions generally used (6,27,37,54,56). However, 
cross-reactions with other bacteria cannot be excluded as a 
possible explanation for the poor specificity obtained by ELISA, 
since absorption studies were not performed. 
Before serology can be used as the "sole" test to detect 
C. pylori infection, both specificity and sensitivity need to be 
improved. Current work in progress is designed to improve 
sensitivity and specificity of serological assays using 
monoclonal antibodies to purify specific antigens to C. pylori. 
28 
The approach of using ~. pylori specific urease as antigen (58) 
is an interesting serological meth od to detect C. pylori. 
29 
CONCLUSIONS 
In conclusion, these studies confirm that ~. pylori is 
strongly associated with histological gastritis and duodenal 
lesions. However, further investigations are needed in order to 
resolve whether ~. pylori actually causes gastritis and peptic 
ulceration, or whether prior tissue damage enables the 
microorganism to act as an opportunist. Although information 
about ~. pylori has accumulated rapidly, more therapeutic studies 
are required to determine the optimal therapies for ~. pylori-
associated gastritis and peptic ulcer disease and to fully 
understand its role, if any, in ~he aetiology of peptic ulcers. 
An aetiological role for ~. pylori in peptic ulcer disease would 
have tremendous clinical, therapeutic and financial implications, 
since maintenance therapy with H2-antagonists to prevent peptic 
ulcer relapses is costly and imposes great demands on patients' 
compliance. Furthermore, these agents have no in-vitro or in-
vivo activity against £. pylori (SB). To answer the question of 
its role in peptic ulcer disease, highly sensitive and specific 
diagnostic techniques to detect £. pylori infection, and 
cooperation between gastroenterologists, microbiologists and 
histopathologists is needed. Since no single technique is ideal, 
it is strongly recommended that a combination of tests, 

















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































PLATE 1: HAEMATOXYLIN AND EOSIN- (H & E) STAINED SECTION OF 
GASTRIC MUCOSA (1000X), SHOWING C. PYLORI IN THE PRESENCE 
OF CHRONIC ACTIVE GASTRITIS 
PLATE 2: WARTHIN-STARRY STAINED SECTION OF GASTRIC MUCOSA 
(1000X), SHOWING ~. PYLORI ADJACENT TO THE EPITHELIUM IN 
A GASTRIC GLAND. 
37 
PLATE 3: TINY, COLOURLESS COLONIES OF C. PYLORI ON CHOCOLATE 
AGAR; POSITIVE OXIDASE AND UREASE REACTIONS ARE SHOWN 
38 
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